MicroRNA-130b regulates scleroderma fibrosis by targeting peroxisome proliferator-activated receptor γ. (Q53651758)

16 May 2018

title

MicroRNA-130b regulates scleroderma fibrosis by targeting peroxisome proliferator-activated receptor γ. (English)

1 reference

16 May 2018

1 reference

Hui Luo

1

1 reference

16 May 2018

Honglin Zhu

2

1 reference

16 May 2018

Bin Zhou

3

1 reference

16 May 2018

Xianzhong Xiao

4

1 reference

16 May 2018

Xiaoxia Zuo

5

1 reference

16 May 2018

publication date

11 February 2015

1 reference

16 May 2018

published in

Modern Rheumatology

1 reference

16 May 2018

volume

25

1 reference

16 May 2018

page(s)

595-602

1 reference

16 May 2018

issue

4

1 reference

16 May 2018

Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities

cites work

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.1001311

Transforming growth factor beta as a therapeutic target in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.1001311

Role of transforming growth factor beta in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.1001311

Peroxisome proliferator-activated receptor γ: innate protection from excessive fibrogenesis and potential therapeutic target in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.1001311

Regulation of Matrix Remodeling by Peroxisome Proliferator-Activated Receptor-γ: A Novel Link Between Metabolism and Fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.1001311

Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.1001311

Small non-coding RNAs in animal development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.1001311

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.1001311

MicroRNAs and the regulation of fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.1001311

MicroRNA array analysis of microRNAs related to systemic scleroderma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.1001311

MicroRNA expression abnormalities in limited cutaneous scleroderma and diffuse cutaneous scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.1001311

MicroRNAs: their involvement in fibrosis pathogenesis and use as diagnostic biomarkers in scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.1001311

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.1001311

Analyzing real-time PCR data by the comparative C(T) method

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.1001311

Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.1001311

Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.1001311

Rosiglitazone alleviates the persistent fibrotic phenotype of lesional skin scleroderma fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.1001311

Circulating miR-130b mediates metabolic crosstalk between fat and muscle in overweight/obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.1001311

miR-130 suppresses adipogenesis by inhibiting peroxisome proliferator-activated receptor gamma expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.1001311

PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.1001311

MicroRNA-29, a key regulator of collagen expression in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.1001311

MicroRNA-21 in scleroderma fibrosis and its function in TGF-β-regulated fibrosis-related genes expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.1001311

The antifibrogenic potential of PPARgamma ligands in pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.1001311

PPARγ as a therapeutic target in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.1001311

Toll-like receptor 4 signaling augments transforming growth factor-β responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.1001311

A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.1001311

Wnt/β-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.1001311

Targeting microRNAs with small molecules: from dream to reality

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.1001311

10.3109/14397595.2014.1001311

21 January 2018

Identifiers

DOI

1 reference

16 May 2018

PubMed ID

25547017

1 reference

16 May 2018